Health Sector Response to Viral Hepatitis in the Selected Countries

Health Sector Response to Viral Hepatitis in the Selected Countries

Viral hepatitis is an important public health concern worldwide. The current study aims to compare prevention and control programs of viral hepatitis in Egypt, Georgia, Pakistan and Australia. This is an international comparative analysis study, which by using document review, Australia, Egypt, Paki...

Full description

Bibliographic Details
Main Authors:	Mohamad Ezati Asar, Ebrahim Jaafari Pooyan, Rashid Ramazani, Alireza Oliaeimanesh, Abolghasem Pourreza
Format:	Article
Language:	English
Published:	Amber Publication 2018-04-01
Series:	Journal of Research in Medical and Dental Science
Subjects:	Health Sector Hepatitis strategy Elimination
Online Access:	https://www.jrmds.in/articles/health-sector-response-to-viral-hepatitis-in-the-selected-countries.pdf

Similar Items

The Key Role of Non-governmental Organizations (NGOs) Activities in Viral Hepatitis Elimination Programs
by: Farzaneh Padami, et al.
Published: (2019-03-01)

Elimination of Hepatitis C in Portugal: An Urban Legend?
by: José Velosa, et al.
Published: (2020-02-01)

Towards the elimination of viral hepatitis in Thailand by the year 2030
by: Nawarat Posuwan, et al.
Published: (2020-09-01)

The Evolution of Hepatitis C Treatment
by: Masoomeh Sofian
Published: (2018-10-01)

RESULTS OF THE VIRAL HEPATITIS B ELIMINATION PROGRAMME IN THE NORTH-WEST OF RUSSIA
by: L. Lyalina, et al.
Published: (2019-06-01)

Eliminating viral hepatitis C in Belgium: the micro-elimination approach
by: Dana Busschots, et al.
Published: (2020-02-01)

A micro-elimination approach to addressing hepatitis C in Turkey
by: Ramazan Idilman, et al.
Published: (2020-03-01)

Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework
by: Ste.phanie Popping, et al.
Published: (2018-07-01)

The role of the Primary Healthcare Network in Iran in hepatitis C virus elimination by 2030
by: Masoud Behzadifar, et al.
Published: (2018-07-01)

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals
by: Stephanie Popping, et al.
Published: (2019-01-01)

The case for a universal hepatitis C vaccine to achieve hepatitis C elimination
by: Nick Scott, et al.
Published: (2019-09-01)

Implementation of hepatitis C cure in Australia: one year on
by: Jacqueline A. Richmond, et al.
Published: (2018-04-01)

Point-of-Care Tests for Hepatitis B: An Overview
by: Yinzong Xiao, et al.
Published: (2020-10-01)

The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review
by: Christina Greenaway, et al.
Published: (2018-09-01)

HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Contemporary strategy to control viral hepatitis A in the Russian Federation
by: M. I. Mikhailov, et al.
Published: (2021-05-01)

Possible Strategies for the Implementation of who Program on the Elimination of Hepatitis C in Ukraine by 2030
by: I. Zaytsev, et al.
Published: (2018-06-01)

Serología en hepatitis virales = Serology in viral hepatitis
by: Jaramillo Aristizábal, María Clara, et al.
Published: (2011-03-01)

Hepatitis E virus (HEV)—The Future
by: Joachim Denner
Published: (2019-03-01)

Engaging the private sector in malaria surveillance: a review of strategies and recommendations for elimination settings
by: Adam Bennett, et al.
Published: (2017-06-01)

Hepatitis C Virus Prevalence and Risk Factors in a Village in Northeastern Romania—A Population-Based Screening—The First Step to Viral Micro-Elimination
by: Laura Huiban, et al.
Published: (2021-05-01)

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
by: Jolynne Mokaya, et al.
Published: (2019-06-01)

Estimating regional prevalence of chronic hepatitis C with a capture-recapture analysis
by: Patricia A. M. Kracht, et al.
Published: (2021-07-01)

Current status and strategies for the control of viral hepatitis A in Korea
by: Eileen L. Yoon, et al.
Published: (2017-09-01)

Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal
by: Christoph Sarrazin, et al.
Published: (2021-06-01)

A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia
by: Faisal M. Sanai, et al.
Published: (2020-11-01)

Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas
by: Alba Maria Ropero Álvarez, et al.
Published: (2017-04-01)

Elimination of Hepatitis B in Highly Endemic Settings: Lessons Learned in Taiwan and Challenges Ahead
by: Chun-Jen Liu, et al.
Published: (2020-07-01)

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C
by: Stephanie Popping, et al.
Published: (2018-07-01)

Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
by: Sanam Hariri, et al.
Published: (2020-10-01)

Prevention of Viral Hepatitis
by: Neşe SALTOĞLU
Published: (2001-09-01)

Hepatitis viral aguda
by: Héctor Rubén Hernández Garcés, et al.
Published: (1998-10-01)

Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access
by: Nick Scott, et al.
Published: (2018-04-01)

Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019
by: Anna Maisa, et al.
Published: (2021-05-01)

VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
by: Sara Mahmoud, et al.
Published: (2010-02-01)

VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
by: Sanaa M. Kamal, et al.
Published: (2010-02-01)

Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits
by: Nick Scott, et al.
Published: (2021-05-01)

Hepatitis Virales
by: Julio Gerardo Mora Campos, et al.
Published: (2019-08-01)

THE MORBIDITY OF VIRAL HEPATITIS B IN THE REPUBLIC OF BURYATIA
by: S. S. Khankhareev, et al.
Published: (2012-09-01)

ELIMINATION OF VIRAL HEPATITIS: CURRENT STRATEGIES AND ISSUES
by: Matsiyeuskaya N. V.
Published: (2019-12-01)